WilmerHale Represents Placement Agent in $60M Provention Bio Private Placement

WilmerHale Represents Placement Agent in $60M Provention Bio Private Placement

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale represented the sole placement agent in the private placement of 13,318,535 shares of common stock and warrants to purchase up to 13,318,535 shares of common stock of Provention Bio, Inc., a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The private placement priced on July 7, 2022 at $4.38 per share and $0.125 per warrant and closed on July 13, 2022, resulting in gross proceeds to Provention of approximately $60 million, before deducting placement agent fees and offering expenses. The private placement investors included Sessa Capital and Armistice Capital Master Fund Ltd. The WilmerHale team advising the sole placement agent consisted of Lisa Firenze, Glenn Pollner, Katharine Patterson and Kevin Cheng, with assistance from Bruce Manheim and Colleen Superko.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel